Intervention Review

You have free access to this content

Anticonvulsants for fibromyalgia

  1. Nurcan Üçeyler1,
  2. Claudia Sommer1,
  3. Brian Walitt2,
  4. Winfried Häuser3,*

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 16 OCT 2013

Assessed as up-to-date: 30 AUG 2013

DOI: 10.1002/14651858.CD010782

How to Cite

Üçeyler N, Sommer C, Walitt B, Häuser W. Anticonvulsants for fibromyalgia. Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010782. DOI: 10.1002/14651858.CD010782.

Author Information

  1. 1

    University of Würzburg, Department of Neurology, Würzburg, Germany

  2. 2

    Washington Hospital Center, Georgetown University Medical Center, Washington, DC, USA

  3. 3

    Technische Universität München, Department of Psychosomatic Medicine and Psychotherapy, München, Germany

*Winfried Häuser, Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Langerstr. 3, München, D-81675, Germany.

Publication History

  1. Publication Status: New
  2. Published Online: 16 OCT 2013


Cited in:


This article has been cited by:

  1. 1
    David Tauben, Nonopioid Medications for Pain, Physical Medicine and Rehabilitation Clinics of North America, 2015, 26, 2, 219


  2. 2
    Julia Bidonde, Angela J Busch, Sandra C Webber, Candice L Schachter, Adrienne Danyliw, Tom J Overend, Rachel S Richards, Tamara Rader, Aquatic exercise training for fibromyalgia, The Cochrane Library,
  3. 3
    Winfried Häuser, Brian Walitt, Petra Klose, Mary-Ann Fitzcharles, Cannabinoids for fibromyalgia, The Cochrane Library,
  4. 4
    Brian Walitt, Gerard Urrútia, María Betina Nishishinya, Sarah E Cantrell, Winfried Häuser, Selective serotonin reuptake inhibitors for fibromyalgia syndrome, The Cochrane Library,